Litigation
Jan. 21, 2004
Pharmaceutical Rivals Unite to Save Settlement
Two companies that duked it out for 12 years over a patent found themselves in court again recently, this time sitting at the same table to defend their previous settlement agreement.
A federal judge last month agreed with their arguments and threw out a claim from MedImmune Inc., a biotech company that licensed th...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In